Select Page

FW: Skin preperation agents for peripheral IV cannulation

Home Forums Infexion Connexion FW: Skin preperation agents for peripheral IV cannulation

 | Click to Receive Email Notifications of Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #70742
    Teresa Lewis
    Participant

    Author:
    Teresa Lewis

    Email:
    tlewis@NEWCASTLEENDOSCOPY.COM.AU

    Organisation:

    State:

    Dear Fiona

    You ask a good question.

    We are a private Endoscopy Centre, so all our cannulas are peripherally inserted and insitu for <24hrs (usually in for 3 – 4.hrs max).

    I saw the NSW Health published guideline called Peripheral Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult Patients too.
    We discussed the very point you are looking at and looked at the ANTT guidelines and the EPIC2 guidelines and like yourself we are aware of IVC related BSIs occurring when the PIVC has been insitu for <24hrs.
    We came to the conclusion that unless the patient had a chlorhexidine allergy/sensitivity we would continue to use the 2 %chlorhexidine 70%V/v Isopropyl alcohol solution (prep pad).

    (The cannula is being inserted into a blood vessel, I hesitate to ask …. how relevant is it, that it's only insitu for a limited amount of time? Aren't we wanting to ensure that skin antisepsis is carried out as per evidence based best practice prior to the cannula being inserted? The next question I want to ask is, if we only need to use 70% alcohol for skin antisepsis for PIVCs that are in situ for 70% alcohol solutions/swabs should be used (to reduce unnecessary exposure to chlorhexidine when residual antimicrobial activity is not required”

    In the guideline appendix 5 it states that
    “For a cannula that is likely to be in for <24hours, skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all PIVC insertions unless the person has a known sensitivity. We are currently reviewing this and are inclined to continue with this product as we have known of IVC related BSIs occurring when a PIVC has been insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep for this cohort of patients.
    Kind regards,

    Fiona De Sousa
    Infection Prevention & Control Coordinator
    Sydney Adventist Hospital
    Fiona.Desousa@sah.org.au
    185 Fox Valley Road, Wahroonga, NSW, 2076

    If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ________________________________
    [Image removed by sender.]

    This email is free from viruses and malware because avast! Antivirus protection is active.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70743
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    Michael.Wishart@hsn.org.au

    Organisation:

    State:

    Hi Teresa

    Your question about which antiseptic to use for access site disinfection is an important one. There is really not much evidence around which antiseptic is better for this purpose, although logic suggests that alcohol alone would be just as effective as a combination of chlorhexidine and alcohol for this use. The rational for this would be looking at the instantaneous antimicrobial activity of alcohol, which is very good, and the utility of a residual effect with chlorhexidine in this use. Since the port/hub/ access site becomes closed (should!) immediately after use, residual effect should not be important here, unlike a skin site, which will always have some access for microbes whilst a cannula is in situ, so residual effect is important.

    Another factor to consider is staff compliance with specific product use. If you provide both alcohol only and chlorhexidine and alcohol swabs, you run the risk of staff choosing one or the other for any purpose. If you only supply alcohol only for chlorhexidine sensitive patients, and supply chlorhexidine and alcohol for everything else, you are more likely to have chlorhexidine and alcohol use appropriately for skin antisepsis.

    I am not aware of any reports of damage to ports/access sites/hubs from chlorhexidine, so I am not aware that is a factor in this discussion, but it is worthy checking with product manufacturers.

    Cheers
    Michael

    Michael Wishart
    Infection Control Coordinator
    Holy Spirit Northside Private Hospital
    627 Rode Road, Chermside, Qld 4032
    t: (07) 3326 3068 | f: (07) 3607 2226
    e: Michael.Wishart@hsn.org.au
    w:www.holyspiritnorthside.org.au
    Please consider the environment before printing this email

    [cid:image001.png@01CF1C06.CBFE0EC0]

    Dear Fiona

    You ask a good question.

    We are a private Endoscopy Centre, so all our cannulas are peripherally inserted and insitu for <24hrs (usually in for 3 – 4.hrs max).

    I saw the NSW Health published guideline called Peripheral Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult Patients too.
    We discussed the very point you are looking at and looked at the ANTT guidelines and the EPIC2 guidelines and like yourself we are aware of IVC related BSIs occurring when the PIVC has been insitu for <24hrs.
    We came to the conclusion that unless the patient had a chlorhexidine allergy/sensitivity we would continue to use the 2 %chlorhexidine 70%V/v Isopropyl alcohol solution (prep pad).

    (The cannula is being inserted into a blood vessel, I hesitate to ask …. how relevant is it, that it's only insitu for a limited amount of time? Aren't we wanting to ensure that skin antisepsis is carried out as per evidence based best practice prior to the cannula being inserted? The next question I want to ask is, if we only need to use 70% alcohol for skin antisepsis for PIVCs that are in situ for 70% alcohol solutions/swabs should be used (to reduce unnecessary exposure to chlorhexidine when residual antimicrobial activity is not required”

    In the guideline appendix 5 it states that
    “For a cannula that is likely to be in for <24hours, skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all PIVC insertions unless the person has a known sensitivity. We are currently reviewing this and are inclined to continue with this product as we have known of IVC related BSIs occurring when a PIVC has been insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep for this cohort of patients.
    Kind regards,

    Fiona De Sousa
    Infection Prevention & Control Coordinator
    Sydney Adventist Hospital
    Fiona.Desousa@sah.org.au
    185 Fox Valley Road, Wahroonga, NSW, 2076

    If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ________________________________
    [Image removed by sender.]

    This email is free from viruses and malware because avast! Antivirus protection is active.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ________________________________
    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    http://www.mailguard.com.au

    Report this message as spam


    WARNING : This email contains information, which is CONFIDENTIAL, and that maybe subject to LEGAL PRIVILEGE. This e-mail and any attachments to it (the “Communication”) is confidential and is for the use only of the intended recipient, and may not duplicated or used by any other party without the express consent of the sender. The Communication may contain copyright material of St Vincent’s Health & Aged Care(“SVHAC”), or any of its related entities or of third parties. If you are not the intended recipient of the Communication, please notify the sender immediately by return e-mail, delete the Communication, and do not read, copy, print, retransmit, store or act in reliance on the Communication. Any views expressed in the Communication are those of the individual sender only, unless expressly stated to be those of SVHAC. SVHAC does not guarantee the integrity of the Communication, or that it is free from errors, viruses or interference. Thank-you.

    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    http://www.mailguard.com.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70751
    Fiona de Sousa
    Participant

    Author:
    Fiona de Sousa

    Email:
    Fiona.DeSousa@SAH.ORG.AU

    Organisation:

    State:

    Thank you everyone for your on and off line responses.

    Kind regards,

    Fiona De Sousa
    Infection Prevention & Control Coordinator
    Sydney Adventist Hospital
    Fiona.Desousa@sah.org.au
    185 Fox Valley Road, Wahroonga, NSW, 2076

    Dear Fiona

    You ask a good question.

    We are a private Endoscopy Centre, so all our cannulas are peripherally inserted and insitu for <24hrs (usually in for 3 – 4.hrs max).

    I saw the NSW Health published guideline called Peripheral Intravenous Cannula (PIVC) Insertion and Post Insertion Care in Adult Patients too.
    We discussed the very point you are looking at and looked at the ANTT guidelines and the EPIC2 guidelines and like yourself we are aware of IVC related BSIs occurring when the PIVC has been insitu for <24hrs.
    We came to the conclusion that unless the patient had a chlorhexidine allergy/sensitivity we would continue to use the 2 %chlorhexidine 70%V/v Isopropyl alcohol solution (prep pad).

    (The cannula is being inserted into a blood vessel, I hesitate to ask …. how relevant is it, that it's only insitu for a limited amount of time? Aren't we wanting to ensure that skin antisepsis is carried out as per evidence based best practice prior to the cannula being inserted? The next question I want to ask is, if we only need to use 70% alcohol for skin antisepsis for PIVCs that are in situ for 70% alcohol solutions/swabs should be used (to reduce unnecessary exposure to chlorhexidine when residual antimicrobial activity is not required”

    In the guideline appendix 5 it states that
    “For a cannula that is likely to be in for <24hours, skin cleaning with at least 70% alcohol is sufficient"

    Our facility currently uses an alcoholic chlorhexidine skin prep for all PIVC insertions unless the person has a known sensitivity. We are currently reviewing this and are inclined to continue with this product as we have known of IVC related BSIs occurring when a PIVC has been insitu for less that the 24 hours outlined in this document.

    We are interested to know what other facilities are using as skin prep for this cohort of patients.
    Kind regards,

    Fiona De Sousa
    Infection Prevention & Control Coordinator
    Sydney Adventist Hospital
    Fiona.Desousa@sah.org.au
    185 Fox Valley Road, Wahroonga, NSW, 2076

    If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ________________________________
    [Image removed by sender.]

    This email is free from viruses and malware because avast! Antivirus protection is active.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    If you are not the intended recipient you are hereby notified that any dissemination, distribution or reproduction of this message
    is prohibited. If you have received this message in error please notify the sender immediately, then destroy the original message.
    Any views expressed in this message are solely those of the individual sender, except where the sender is specifically authorised
    by Adventist HealthCare Limited to state that they are the views of Adventist HealthCare Limited.
    _____________________________________________________________________
    This e-mail has been scanned for viruses by Symantec Hosted Services
    Scanning Services – powered by MessageLabs. For further information
    visit http://www.messagelabs.com

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 3 posts - 1 through 3 (of 3 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.